Bristol-Myers Squibb

+$1.05 (+1.64%) Today

+$0.09 (+0.14%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BMY and other ETFs, options, and stocks.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics.

CEO

Giovanni Caforio

Employees

30,250

Headquarters

New York, New York

Founded

1933

BMY Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

3.02

Average volume

13.34M

High today

$64.92

Low today

$63.25

Open price

$63.68

Volume

10.85M

52 Week high

$69.75

52 Week low

$53.22

BMY News

The Wall Street JournalJan 26

Democrats Find a Pharma Scapegoat

Democrats this week are renewing their calls to cap prescription drug prices, and Sen. Ron Wyden has found a scapegoat in the cause. The Senate Finance Chairman

Analyst ratings

Buy

62.5%

Hold

37.5%

Sell

BMY Earnings

$0.00

$0.67

$1.33

$2.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

$1.80 per share

Actual

Available Feb 4, Pre-Market

Why Robinhood?

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. View more

Democrats Find a Pharma Scapegoat

63%

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics.